Literature DB >> 35616718

Increased blood levels of venetoclax due to intake of crushed venetoclax tablets.

Maiko Anzai1, Takeo Yasu2,3, Yoshito Gando4, Mikio Shirota1, Masayuki Kobayashi5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35616718     DOI： 10.1007/s00277-022-04871-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   4.030


× No keyword cloud information.
  5 in total

1.  Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.

Authors:  Fang Liu; Ambreen Ghaffur; Jackreet Bains; Shaheen Hamdy
Journal:  Int J Pharm       Date:  2016-03-09       Impact factor: 5.875

2.  The efficacy and adverse events of venetoclax in combination with hypomethylating agents treatment for patients with acute myeloid leukemia and myelodysplastic syndrome: a systematic review and meta-analysis.

Authors:  Bei Liu; Yuancheng Guo; Lijuan Deng; Yanhong Qiao; Jinli Jian
Journal:  Hematology       Date:  2020-12       Impact factor: 2.269

3.  Effect of Low- and High-Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First-in-Class BCL-2 Inhibitor.

Authors:  Ahmed Hamed Salem; Suresh K Agarwal; Martin Dunbar; Silpa Nuthalapati; David Chien; Kevin J Freise; Shekman L Wong
Journal:  J Clin Pharmacol       Date:  2016-11       Impact factor: 3.126

4.  Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.

Authors:  Courtney D DiNardo; Brian A Jonas; Vinod Pullarkat; Michael J Thirman; Jacqueline S Garcia; Andrew H Wei; Marina Konopleva; Hartmut Döhner; Anthony Letai; Pierre Fenaux; Elizabeth Koller; Violaine Havelange; Brian Leber; Jordi Esteve; Jianxiang Wang; Vlatko Pejsa; Roman Hájek; Kimmo Porkka; Árpád Illés; David Lavie; Roberto M Lemoli; Kazuhito Yamamoto; Sung-Soo Yoon; Jun-Ho Jang; Su-Peng Yeh; Mehmet Turgut; Wan-Jen Hong; Ying Zhou; Jalaja Potluri; Keith W Pratz
Journal:  N Engl J Med       Date:  2020-08-13       Impact factor: 91.245

5.  Pill Properties that Cause Dysphagia and Treatment Failure.

Authors:  Jeremy Fields; Jorge T Go; Konrad S Schulze
Journal:  Curr Ther Res Clin Exp       Date:  2015-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.